UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Budget impact analysis of continuous glucose monitoring in individuals with type 2 diabetes on insulin treatment in England

Health economics review, 2024-05, Vol.14 (1), p.32-32, Article 32

2024

Volltextzugriff (PDF)

Estimating the budget impact of adopting tenofovir/emtricitabine for pre-exposure prophylaxis of HIV in the public health sector in Namibia (2021 – 2023)

Journal of infection and public health, 2022-10, Vol.15 (10), p.1147-1155

2022

Volltextzugriff (PDF)

Research gaps and Health Technology Assessment

Farmeconomia. Health economics and therapeutic pathways, 2014-06, Vol.15 (2), p.35-37

Barham, Leela

2014

Volltextzugriff (PDF)

The public and patients should have their say in HTA

Farmeconomia. Health economics and therapeutic pathways, 2012-06, Vol.13 (2), p.45-47

Barham, Leela

2012

Volltextzugriff (PDF)

PP409 Cost-Effectiveness Of Ruxolitinib For Patients With Myelofibrosis: A Review Of The Literature

International journal of technology assessment in health care, 2021-12, Vol.37 (S1), p.35-35

2021

Volltextzugriff (PDF)

Public and Patient Involvement at the UK National Institute for Health and Clinical Excellence

The patient : patient-centered outcomes research, 2011, Vol.4 (1), p.1-10

Barham, Leela

2011

Volltextzugriff (PDF)

Single Technology Appraisals by NICE: Are They Delivering Faster Guidance to the NHS?

PharmacoEconomics, 2008-01, Vol.26 (12), p.1037-1043

Barham, Leela

2008

Volltextzugriff (PDF)

The Budget Impact Analysis of Adopting Direct Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation Patients in Malawi

Value in health regional issues, 2023-09, Vol.37, p.53-61

2023

Volltextzugriff (PDF)

The Use of Economic Evaluation Tools in Essential Health Benefits Package Selection for Universal Health Coverage

Value in health regional issues, 2023-07, Vol.36, p.1-9

2023

Volltextzugriff (PDF)

Economic Burden of Chronic Pain Across Europe

Journal of pain & palliative care pharmacotherapy, 2012-03, Vol.26 (1), p.70-72

Barham, Leela

2012

Volltextzugriff (PDF)

Starting on the path to high patient satisfaction with health care in India

North American journal of medical sciences, 2012-09, Vol.4 (9), p.411-411

Barham, Leela

2012

Volltextzugriff (PDF)

Economic Crisis: Consequences for Patients, Chronic Pain Clinics, and the Pharmaceutical Industry

Journal of pain & palliative care pharmacotherapy, 2011-11, Vol.25 (4), p.382-385

Barham, Leela

2011

Volltextzugriff (PDF)

Is the NHS getting better or worse? Making use of information is the key

BMJ, 2004-01, Vol.328 (7431), p.106-106

Barham, Leela M

International edition, 2004

Volltextzugriff (PDF)

Patient-reported outcome measures: implications for nursing

Nursing standard, 2011-01, Vol.25 (18), p.42-45

2011

Volltextzugriff (PDF)

Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe

Applied health economics and health policy, 2023-07, Vol.21 (4), p.537-546

2023

Volltextzugriff (PDF)

Patient-reported outcome measures: implications for nursing

Nursing standard, 2011-01, Vol.25 (18), p.42-45

2011

Volltextzugriff (PDF)

Editorial April 2011: New regulation for primary care

Primary health care, 2011-04, Vol.21 (3), p.3-3

Barham, Leela

2011

Volltextzugriff (PDF)

The Affordability vs. Access Dilemma

Pharmaceutical Executive, 2017-04, Vol.37 (4), p.32

Barham, Leela

2017

Volltextzugriff (PDF)

Will NICE 'Go Commercial'?

Pharmaceutical Executive, 2016-12, Vol.36 (12), p.14

Barham, Leela

2016

Volltextzugriff (PDF)

European Pharma and the Unified Patent Court

Pharmaceutical Executive, 2016-08, Vol.36 (8), p.37

Barham, Leela

2016

Volltextzugriff (PDF)

What Does the UK's 'New' Government Mean for the Industry?

Pharmaceutical Executive, 2015-06, Vol.35 (6), p.14

Barham, Leela

2015

Volltextzugriff (PDF)

Tackling client violence in female street prostitution: Inter-agency working between outreach agencies and the police

Policing & society, 2004-12, Vol.14 (4), p.365-379

2004

Volltextzugriff (PDF)

The Queen's English

Pharmaceutical Executive, 2012-08, Vol.32 (8), p.72

Barham, Leela

2012

Volltextzugriff (PDF)

The affordability vs. Access dilemma: newly overhauled measures for how new drugs are appraised in the UK may not strike the right balance

Pharmaceutical executive, 2017-04, Vol.37 (4), p.32

Barham, Leela

2017

Volltextzugriff (PDF)

Will NICE 'go commercial'? That may be one option as the UK agency, like the NIH it supports, looks at how to generate big savings

Pharmaceutical executive, 2016-12, Vol.36 (12), p.14

Barham, Leela

2016

Volltextzugriff (PDF)

1 – 25 von 33

Menü

Weitere Dienste

Einstellungen

Budget impact analysis of continuous glucose monitoring in individuals with type 2 diabetes on insulin treatment in England

Estimating the budget impact of adopting tenofovir/emtricitabine for pre-exposure prophylaxis of HIV in the public health sector in Namibia (2021 – 2023)

Research gaps and Health Technology Assessment

The public and patients should have their say in HTA

PP409 Cost-Effectiveness Of Ruxolitinib For Patients With Myelofibrosis: A Review Of The Literature

Public and Patient Involvement at the UK National Institute for Health and Clinical Excellence

Single Technology Appraisals by NICE: Are They Delivering Faster Guidance to the NHS?

The Budget Impact Analysis of Adopting Direct Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation Patients in Malawi

The Use of Economic Evaluation Tools in Essential Health Benefits Package Selection for Universal Health Coverage

Economic Burden of Chronic Pain Across Europe

Starting on the path to high patient satisfaction with health care in India

Economic Crisis: Consequences for Patients, Chronic Pain Clinics, and the Pharmaceutical Industry

Is the NHS getting better or worse? Making use of information is the key

Patient-reported outcome measures: implications for nursing

Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe

Patient-reported outcome measures: implications for nursing

Editorial April 2011: New regulation for primary care

The Affordability vs. Access Dilemma

Will NICE 'Go Commercial'?

European Pharma and the Unified Patent Court

What Does the UK's 'New' Government Mean for the Industry?

Tackling client violence in female street prostitution: Inter-agency working between outreach agencies and the police

The Queen's English

The affordability vs. Access dilemma: newly overhauled measures for how new drugs are appraised in the UK may not strike the right balance

Will NICE 'go commercial'? That may be one option as the UK agency, like the NIH it supports, looks at how to generate big savings

Suchergebnisse filtern